Skip to main content

Creeping Complacency In Marijuana-stock Investing Is A Possible Warning Sign

Serious marijuana investors ought to pay attention to the complacency that’s creeping into the stock market. Historically when complacency abounds, stocks fall, unless there are new positive fundamental developments or new short-squeezes.

A lot of money is to be made in marijuana. However, there are times when it is important to preserve capital. Since I wrote “How to potentially become a marijuana millionaire, albeit carefully,” a lot of money has been made in marijuana stocks by following segmented money flows. Let’s explore the latest money flows in marijuana stocks with the help of a chart.

Read: For these ‘marijuana moms,’ working in cannabis lets their families live the good life

Chart

Please click here for a chart showing segmented money flows in 17 popular marijuana stocks. Please note the following:

• As the chart shows, Tilray TLRY, -0.97% has lost the No. 1 non-risk-adjusted ranking and is now No. 3. Aphria APHA, -0.43% is now ranked No. 1.

• Canopy Growth CGC, -1.26% continues to hold the top spot in the risk-adjusted-ranking. (More on rankings later.)

• Momentum (momo) crowd money flows are extremely positive in Curaleaf CURLF, +5.39% There is a lot of excitement about Curaleaf providing CBD products to CVS CVS, +0.45% the largest drug-store chain. This is a major positive development for marijuana investors. However, smart-money flows in Curaleaf are negative. This indicates that the “up” move in Curaleaf is overdone. (The smart money is professional investors.)

• Momo crowd money flows in Cronos CRON, -2.52% are very positive. Cronos has an investment from cigarette giant Altria MO, +0.34% However, smart money flows in Cronos are mildly negative.

• Aurora Cannabis ACB, -1.25% got a boost when it attracted Nelson Peltz as an adviser. Peltz is an accomplished person and will certainly be a big help to Aurora Cannabis. Momo crowd money flows in Aurora Cannabis are positive but smart money flows are mildly negative.

• Acreage Holdings ACRGF, -4.26% has attracted a number of politicians to its board. However, in spite of heavy publicity, momo crowd money flows have fallen from extremely positive to positive.

• Momo crowd money flows continue to be positive in marijuana ETF MJ, -0.91% New Age Beverages NBEV, +0.00% MedMen MMNFF, +0.58% and Liberty Health LHSIF, -2.54%

• Among cannabis-related stocks, Corbus Pharmaceuticals CRBP, +0.00% is the only one with positive money flows. In reality, this is a small biotech that gets grouped with cannabis stocks.

• The other biotech, GW Pharmaceuticals GWPH, +1.41% which has an approved FDA drug, is also seeing negative smart money flows.

• Among popular marijuana-related stocks, KushCo Holdings KSHB, -1.76%  aka Kush Bottles, Craft Brew Alliance BREW, +0.07% Scotts Miracle-Gro SMG, -0.37% and Constellation Brands STZ, +0.00% are seeing negative smart money flows.

Ask Arora: Nigam Arora answers your questions about investing in stocks, ETFs, bonds, gold and silver, oil and currencies. Have a question? Send it to Nigam Arora.

Rankings

The chart shows the relative rankings of the five select popular marijuana stocks. These rankings are based on the six screens of the ZYX Change Method. (Please click here to learn about the six screens.)

Risk-adjusted rankings are more useful for medium- and long-term positions. Non-risk-adjusted rankings are more useful for short-term or trade-around positions.

What to do now

It is important for investors to understand that significant complacency has creeped into marijuana stocks. Due to this complacency, marijuana stocks are experiencing significantly less volatility than before. This often occurs before a major change happens — change can be to the upside or to the downside. In this case, the probability is 60% of a downside move, 20% of an upside move and 20% of these stocks staying range-bound.

Consider using the foregoing probability information to assess your marijuana portfolio to make sure that you are holding only those positions that you want to hold for the long term and the total investment in marijuana stocks is in line with your personal risk preferences. If you are still holding positions in marijuana stocks for the short term, consider taking profits. To be clear, this is not a call to sell long-term core positions that are properly sized.

Arora’s 14th Law is directly applicable in this situation: To be successful at investing and trading, become a master of position sizing. Position sizing is critical to investing in marijuana stocks. In addition, using techniques such as trade-around positions is especially important.

Those not in marijuana stocks may consider waiting patiently for signals to buy select marijuana stocks. There is too much risk in buying these stocks today. Of course, there is an exception in buying new special situations in marijuana stocks as they develop.

Disclosure: Subscribers to The Arora Report may have positions in the securities mentioned in this article or may take positions at any time. Nigam Arora is an investor, engineer and nuclear physicist by background who has founded two Inc. 500 fastest-growing companies. He is the founder of The Arora Report, which publishes four newsletters. Nigam can be reached at Nigam@TheAroraReport.com.

Original Article Source: http://www.marketwatch.com/news/story.asp?guid=%7B74CA4A72-50A5-11E9-AE07-165B289D3DB1%7D&siteid=rss&rss=1

Comments

Post a Comment

Popular posts from this blog

New York City Adds More Exceptions To Pre-Employment Marijuana Testing Ban

An ambitious campaign to decriminalize psychedelics in Washington, D.C., is one step closer to placing their measure on the November ballot with the formal submission of tens of thousands of voter signatures. Organizers have been scrambling for weeks to collect enough signatures from D.C. voters by Monday’s deadline amid historically difficult circumstances: a global pandemic, months of stay-at-home orders and protests over racism and police violence that filled the streets of the nation’s capital. But with the help of innovative signature-gathering techniques and allies flown in from across the country, advocates said they had successfully submitted upwards of 35,000 signatures—more than enough to qualify the initiative. If approved by voters, Initiative 81 would make enforcement of laws against plant- and fungus-based psychedelics among the “lowest law enforcement priorities” for the Metropolitan Police Department. It would not, however, legalize or reduce penalties for the subs
Post a Comment
Read more

Charlotte Figi The Girl Who Inspired A CBD Movement Has Died At Age 13

Charlotte had recently been hospitalized due to pneumonia, breathing problems and seizures. She was treated as a likely case of Covid-19, her mother, Paige Figi, said Wednesday, although she tested negative for the virus. “Charlotte is no longer suffering. She is seizure-free forever,” a family friend wrote on Paige Figi’s Facebook page, announcing Charlotte’s death. “Thank you so much for all of your love.” Charlotte became a symbol of the possibilities of CBD after CNN Chief Medical Correspondent Dr. Sanjay Gupta told her story in the documentary “Weed.” In the film, Charlotte was shown to be a playful child who was overcome by horrific seizures, which were quelled with Charlotte’s Web, a marijuana strain named in her honor. Charlotte had Dravet syndrome, a rare form of epilepsy which was not controlled by medication. The Stanley brothers, marijuana growers in Colorado, were crossbreeding a strain of marijuana high in CBD and low in THC, its psychoactive ingredient. After Charlo
Post a Comment
Read more

Virginia CBD Program Criticized As Multistate Medical Cannabis Operators Gain Edge

Seven companies are challenging a CBD licensing process in Virginia that resulted in multistate medical marijuana operators getting a majority of available licenses. The appeals called the process “wildly prejudicial.” Out of 51 applicants for five vertically integrated CBD and THC-A licenses, multistate operators received three, a situation that spurred the appeals, The Virginian-Pilot reported. Applicants filing the appeals complained the closed-meeting review process lacked fairness and transparency. One consultant to an applicant said the selections felt “predetermined.” The Virginia Board of Pharmacy reportedly sent information to the applicants in December explaining its selections, but some applicants weren’t satisfied. A board spokeswoman wrote in an email to the Pilot that the board “does not comment on pending litigation.” The five winning applicants , called “pharmaceutical processors,” have a year from winning the licenses to become operational. The multistate
Post a Comment
Read more